We’re a science-led global healthcare company that researches and develops a broad range of innovative products in three primary areas of pharmaceuticals, vaccines and consumer healthcare.
GlaxoSmithKline plc was formed in 2000 as a result of a merger between Glaxo Wellcome plc and SmithKline Beecham plc , although our history can be traced back much further than that to London’s Plough Court Pharmacy in the 1700s.
In March 2015 we completed a three-part transaction with Novartis which reshapes our business.
We acquired Novartis’s vaccines business (excluding influenza vaccines) and combined our Consumer Healthcare businesses to create a new company. By substantially strengthening Vaccines and Consumer Healthcare, we can deliver far-reaching benefits to patients and consumers, and further value to shareholders. In addition, Novartis acquired our marketed Oncology portfolio.
If you’re looking to find out more about how and where we operate, or the kind of research we’re doing you’ll find lots of information on this site. It covers our business here in the UK, including details on our work with the NHS, patient groups and charities.